Tilray stock analysis
Tilray (TLRY) Stock Price & Analysis
TLRY Stock Chart & Stats
- Day’s Range
- CAD 3.45 - CAD 3.60
- 52-Week Range
- CAD 3.45 - CAD 21.57
- Previous Close
- CAD 3.53
- Volume
- N/A
- Average Volume (3M)
- 682.84K
- Market Cap
- CAD 512.52M
- Enterprise Value
- CAD 743.22M
- Total Cash (Recent Filing)
- CAD 218.01M
- Total Debt (Recent Filing)
- CAD 371.93M
- Price to Earnings (P/E)
- ―
- Beta
- 2.06
- Next Earnings
- Jan 11, 2027 (Est.)
- EPS Estimate
- -0.22
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Revenue And Margin Growth
Record quarterly revenue and gross profit, together with expanding margins, indicate stronger operating scale and improved commercial execution. If sustained, this combination can increase reinvestment capacity, support fixed-cost absorption, and strengthen earnings quality over the next several quarters.
Global Diversified Platform
A diversified platform across products, geographies, and consumer categories reduces reliance on any single market and creates multiple routes to growth. International infrastructure, brand breadth, and pharmaceutical distribution can provide durable cross-selling and expansion opportunities.
Debt Reduction
Debt repayment and substantial liquidity improve financial flexibility while reducing future interest and refinancing pressure. Continued balance-sheet improvement can preserve resources for growth investments and make the company better positioned to manage volatility in cannabis and beverage markets.
Bears Say
Negative Cash Generation
Persistent negative operating and free cash flow means the business is not yet self-funding, despite some improvement from the prior period. Continued cash burn can constrain investment, increase reliance on financing actions, and reduce resilience if operating conditions weaken.
Cannabis Revenue And Pricing Pressure
Cannabis remains a core business, yet falling revenue and international price compression are limiting gross-profit growth. Even with better reported margins, sustained pricing pressure can weaken scale benefits, reduce segment earnings, and make the company more dependent on other categories.
Interest And Maturity Burden
Ongoing interest expense absorbs cash while the approaching maturity requires continued capital-structure management. Although debt has been reduced, refinancing or further exchanges could consume management attention, create dilution risk, and limit funds available for operating expansion.
Tilray News
TLRY FAQ
What was Tilray’s price range in the past 12 months?
What is Tilray’s market cap?
When is Tilray’s upcoming earnings report date?
How were Tilray’s earnings last quarter?
Is Tilray overvalued?
Does Tilray pay dividends?
What is Tilray’s EPS estimate?
How many shares outstanding does Tilray have?
What happened to Tilray’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Tilray?
What is the TipRanks Smart Score and how is it calculated?
Tilray Stock Smart Score
Company Description
Tilray
Tilray Brands, Inc. is a diversified global consumer packaged goods company primarily involved in the cultivation, processing, marketing, and sale of cannabis products. Its operations span a significant international footprint, encompassing Canada, the United States, Europe, Australia, New Zealand, and Latin America. The company organizes its business across four distinct divisions: Cannabis, Distribution, Beverage Alcohol, and Wellness. Within its cannabis division, Tilray provides a comprehensive range of medical and adult-use items, including regulated products like GMP-certified cannabis flowers, oils, vaporizers, edibles, and topical applications. Beyond cannabis, Tilray's portfolio extends to the procurement and resale of pharmaceutical and wellness goods. Furthermore, it manufactures, promotes, and distributes a variety of alcoholic beverages, alongside hemp-derived food and other wellness items. The company markets its diverse offerings under numerous recognized brands, such as Tilray, Aphria, SweetWater, and Breckenridge Distillery. Its products reach a wide array of customers, including retail outlets, wholesale partners, medical patients, healthcare practitioners, hospitals, pharmacies, scientific researchers, governmental bodies, and directly to end consumers. Formerly operating as Tilray, Inc., the corporation is headquartered in Leamington, Canada.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Irwin David Simon
- Employees
- 3,595
- Website
- www.tilray.com
- Address
- 265 Talbot Street West, Leamington, ON, N8H 5L4, CA
Tilray (TLRY) Earnings & Revenues
TLRY Earnings Call
Earnings Call SentimentPositive
The call was predominantly positive. Tilray reported record revenue and gross profit, expanding consolidated and cannabis margins, strong international cannabis and BrewDog growth, U.S. craft beer brand momentum, debt reduction, and reaffirmed fiscal 2027 adjusted EBITDA guidance. These strengths were partly offset by a $40 million net loss, lower adjusted EBITDA, total cannabis revenue contraction, international price compression, Canadian adult-use headwinds, fuel costs, higher investment costs, and continued regulatory and market uncertainty.
View all TSE:TLRY earnings summariesTLRY Stock 12 Month Forecast
Average Price Target
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 4 | 3 | 15 |
| Technical Analysis | 4 | 3 | 3 |
| Moving Averages | 0 | 0 | 12 |













